Nanophase Technologies Corp (NANX) Reports Q2 EPS of $0.00

Go back to Nanophase Technologies Corp (NANX) Reports Q2 EPS of $0.00

Nanophase Reports Record Revenue for Second Quarter as Growth Continues

August 17, 2022 4:00 PM EDT

Delivered a record $11.2 million in Q2 revenue In Beauty Science markets, Solésence revenue is up 44% YOY while Active Pharmaceutical Ingredients (API) sales are up 79%  

ROMEOVILLE, Ill., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories with innovations that protect skin from environmental aggressors and aid in medical diagnostics today announced its second consecutive period of record financial results for the quarter ended June 30, 2022.

We are pleased to see a second consecutive... More